We don't know any of their back history, really
Members pay 9,096/unit Save an extra 20% with Akza membership
Coras compounded semaglutide and tirzepatide are not FDA-approved and are not therapeutically equivalent to the medications studied in those trials

Welsh JA, Goberdhan DCI, ODriscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrgger U, Falcon-Perez JM, Fu Q-L, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Mller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Kuulei-Lyn Faustino V, Kyburz D, Lsser C, Lennon KM, Ltvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ, Consortium M, Thry C, Witwer KW (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches